Eccoti alcune info "stanozolol"
" Havoc (2alpha,3alpha-epithio-17alpha-methyl-5alpha-androstan-17beta-ol) is a methylated derivative of a Japanese anabolic/anti-estrogenic steroid called mepitiostane (Thioderon). As such, it would be most appropriate to call this steroid Meth-epitiostane. Methepitiosane was first described in 1966, so it is technically not a new drug. It was assayed for anabolic and androgenic effect according to the standard animal administration experiments, and was show to display a much stronger tendency for anabolic (as compared to androgenic) actions. It was indeed determined to be a favorable steroid as far as reduced androgenicity was concerned, but never made it much further than that. The drug sat in research obscurity for a long time. That is until the modern 'gold rush' for unknown anabolic steroids that could be sold (albeit less than legally) on the sports nutrition market. Havoc is one of the latest and most talked about additions to this group of ?grey area? drugs.
Havoc does have a few things going for it; at least as far as finding a 'mild' steroid goes. For a given level of anabolic effectiveness (dose), you should notice less oily skin/acne, and will be less likely to shed hair if you are thinning, than you would with many other drugs. You are also not going to have problems with gyno, and the drug may even help to block this if your estrogen levels are a little high naturally or from other substances. But one must not mistake mildness in terms of androgenicity to mean mildness in terms of health risks. Some are mistakenly assuming that Havoc is both less toxic to your liver, and less damaging to your cholesterol, than other oral steroids, and there is nothing to suggest this is true, especially since no investigations into the heath risks of methepitiostane have ever been conducted. We do know that liver toxicity is directly tied to the steroid?s potency and resistance to liver breakdown. Given that methepitiostane is both potent and c-17alpha alkylated, a sufficient level of liver toxicity is assumed. The strongest shifts in HDL/LDL cholesterol are also seen with oral c-17 alpha alkylated steroids; so again, methepitiostane is likely to present some notable concerns here. The bottom line, Havoc is a potent yet mild (weakly androgenic) steroid, but it is still an alkylated oral. It should carry the expected liver and cardiovascular risks of other drugs of this class. Keep this in mind and you should be fine.
|